URIFIND Trademark

Trademark Overview


On Wednesday, July 1, 2020, a trademark application was filed for URIFIND with the United States Patent and Trademark Office. The USPTO has given the URIFIND trademark a serial number of 90030700. The federal status of this trademark filing is REGISTERED as of Tuesday, October 24, 2023. This trademark is owned by AnchorDx Medical Co., Ltd.. The URIFIND trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for tumor therapy; organotherapy preparations; biological tissue cultures for medical purposes; medicine for tumor therapy; radioactive substances for medical purposes; media for bacteriological cultures; dietetic preparations adapted for medical purposes, namely, dietetic substances adapted for adjuvant therapy of tumors; wadding for medical purposes

medical apparatus and instruments for diagnosing and therapeutic treatment of tumors; medical apparatus and instruments for diagnosing urological conditions, namely, urological apparatus and instruments, for IVD (in vitro diagnosis); medical diagnostic apparatus for testing nucleic acids and proteins, all for medical purposes; dialyzers; apparatus for DNA and RNA testing for medical purposes; enema apparatus for medical purposes; surgical apparatus and instruments; urethral probes
urifind

General Information


Serial Number90030700
Word MarkURIFIND
Filing DateWednesday, July 1, 2020
Status700 - REGISTERED
Status DateTuesday, October 24, 2023
Registration Number7202367
Registration DateTuesday, October 24, 2023
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, June 15, 2021

Trademark Statements


Description of MarkThe mark consists of the stylized wording "URIFIND".
Goods and Servicesdiagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for tumor therapy; organotherapy preparations; biological tissue cultures for medical purposes; medicine for tumor therapy; radioactive substances for medical purposes; media for bacteriological cultures; dietetic preparations adapted for medical purposes, namely, dietetic substances adapted for adjuvant therapy of tumors; wadding for medical purposes
Goods and Servicesmedical apparatus and instruments for diagnosing and therapeutic treatment of tumors; medical apparatus and instruments for diagnosing urological conditions, namely, urological apparatus and instruments, for IVD (in vitro diagnosis); medical diagnostic apparatus for testing nucleic acids and proteins, all for medical purposes; dialyzers; apparatus for DNA and RNA testing for medical purposes; enema apparatus for medical purposes; surgical apparatus and instruments; urethral probes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 29, 2020
Primary Code005
First Use Anywhere DateFriday, November 18, 2022
First Use In Commerce DateFriday, November 18, 2022

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, July 29, 2020
Primary Code010
First Use Anywhere DateFriday, November 18, 2022
First Use In Commerce DateFriday, November 18, 2022

Trademark Owner History


Party NameAnchorDx Medical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGuangzhou N/A
CN

Party NameAnchorDx Medical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGuangzhou N/A
CN

Party NameAnchorDx Medical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGuangzhou N/A
CN

Trademark Events


Event DateEvent Description
Tuesday, October 24, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 24, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, September 21, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, September 20, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, September 20, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 10, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, April 10, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, April 3, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 3, 2023NON-FINAL ACTION E-MAILED
Monday, April 3, 2023SU - NON-FINAL ACTION - WRITTEN
Saturday, March 4, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 8, 2023USE AMENDMENT FILED
Monday, February 27, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 8, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, August 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 8, 2022SOU EXTENSION 2 GRANTED
Monday, August 8, 2022SOU EXTENSION 2 FILED
Monday, August 8, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, February 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 7, 2022SOU EXTENSION 1 GRANTED
Monday, February 7, 2022SOU EXTENSION 1 FILED
Monday, February 7, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, August 10, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 15, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 15, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 7, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 6, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 6, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 7, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 7, 2020NON-FINAL ACTION E-MAILED
Wednesday, October 7, 2020NON-FINAL ACTION WRITTEN
Tuesday, October 6, 2020ASSIGNED TO EXAMINER
Wednesday, July 29, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 4, 2020NEW APPLICATION ENTERED